GUMM - Eliminate the Common Cold Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DanZ who wrote (3903)	8/6/2001 10:05:01 AM
From: rli123	of 5582

Dan -- couldn't agree with you more. Clinical studies are not cheap --- and the last thing GUMM is going to do is throw money away doing clinical studies of an irrelevant product -- a product that bears only slight, tangential resemblance to GUMM's commercial product, Zicam. My professional experience tells me that a significant difference in the viscosity of the product can have a profound effect on performance. Afterall, with a low-viscosity spray, the residence time in the nostril would be significantly lessened, compared to a gel. The longer residence time is supposedly one of the keys to why Zicam works. rli

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next